Back to the main directory
EarningsReview / Equity
- Storebrand - Check, check and check by Danske Bank Equity Research
- Topdanmark - Underlying better than headline – all eyes on Sampo by Danske Bank Equity Research
- Non material data changes by BNP Paribas Exane
- Aker Solutions - Flawless quarter adds share price upside by Danske Bank Equity Research
- Evergreen Growth Story by BNP Paribas Exane
- On the cusp of monetary easing by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- XXL ASA (Hold, TP: NOK0.75) - Weak Q2 by DnB Markets
- Public Property Invest (Buy, TP: NOK20.00) - Solid H1, attractive valuation by DnB Markets
- Protector (Buy, TP: NOK270.00) - Large claims quarter by DnB Markets
- Axfood (Buy, TP: SEK320.00) - Looking beyond 2024 hiccups by DnB Markets
- Topdanmark (Hold, TP: DKK371.00) - Continued repricing focus by DnB Markets
- Norske Skog (Buy, TP: NOK60.00) - In good shape by DnB Markets
- Avanza Bank (Hold, TP: SEK255.00) - Benign margin trends for now by DnB Markets
- Arjo (Buy, TP: SEK58.00) - Q2 in line; M&A back on the agenda by DnB Markets
- Stolt-Nielsen Minor model adjustments by DnB Markets
- Q2 reporting season in full swing by DnB Markets
- Paratus Energy - Initiation of coverage - All set for shareholder distributions by DnB Markets
- Entra (Buy, TP: NOK140.00) - Growth is back by DnB Markets
- Pandox (Hold, TP: SEK205.00) - Q2 RevPAR exceeded forecast by DnB Markets
- Lime Technologies (Sell, TP: SEK340.00) - Downgraded to SELL on valuation by DnB Markets
- Aker Biomarine (Buy, TP: NOK120.00) - Q2 in line, maximising value of remaining assets by DnB Markets
- XVIVO Perfusion (Buy, TP: SEK584.00) - Clear signs of scalability in Q2 by DnB Markets
- Aker BP (Hold, TP: NOK290.00) - Jury still out on Sverdrup into 2025 by DnB Markets
- Dunelm Group(DNLM LN) by HSBC
- Axfood - Trouble at the warehouse by Danske Bank Equity Research
- Gränges - Successfully leveraging free capacity by Danske Bank Equity Research
- Chart of the Week: Pepsi’s (US) Challenge; A Reason We Prefer KO vs. PEP by BNP Paribas Exane
- Avanza - Savings tailwinds and investment cost uncertainty by Danske Bank Equity Research
- Perks of a new-found serenity by BNP Paribas Exane
- Snappy quarter by BNP Paribas Exane
- Axfood (Buy, TP: SEK330.00) - Trouble for Dagab hit results by DnB Markets
- Aker Biomarine (Buy, TP: NOK90.00) - Q2 in line with consensus by DnB Markets
- Storebrand (Buy, TP: NOK129.00) - Strong momentum in Savings by DnB Markets
- Sparebanken Øst (Buy, TP: NOK62.00) - Strong Q2 and raised ROE target by DnB Markets
- Elkem (Hold, TP: NOK22.00) - Large one-off drives positive result by DnB Markets
- Norwegian Air Shuttle (Buy, TP: NOK14.00) - Relief by DnB Markets
- Corem (Hold, TP: SEK10.50) - Net lettings above expectations by DnB Markets
- XXL ASA (Hold, TP: NOK0.75) - Q2 disappoints by DnB Markets
- Vår Energi Minor model adjustments by DnB Markets
- Electrolux Minor model adjustments by DnB Markets
- Seafood - Fat Trout Weekly by DnB Markets
- Embracer Group (Buy, TP: SEK45.00) - Looking past uneventful H1 by DnB Markets
- Addtech (Buy, TP: SEK365.00) - From strength to strength by DnB Markets
- TF Bank (Buy, TP: SEK290.00) - BUY case intact by DnB Markets
- Kesko (Hold, TP: EUR17.00) - Narrowing the grocery gap by DnB Markets
- Coor Service Management (Buy, TP: SEK59.00) - Improving in retention rates by DnB Markets
- Bravida (Buy, TP: SEK112.00) - Focus back on opportunities by DnB Markets
- The worst is likely behind by BNP Paribas Exane
- Vitec Software - Silencing the doubters of transactional income by Danske Bank Equity Research